CJ CheilJedang, which backed away from a bio deal, may find a buyer for its 300 billion won starch sugar business

CJ CheilJedang is considering carving out and selling its starch and sugar division to financial investors.

The key issues are the sale price, profitability outlook, and the impact of the Fair Trade Commission’s cartel fine.

The deal would signal how quickly CJ CheilJedang is trimming non-core assets and reshaping its portfolio.

A valuation around KRW 300 billion is being discussed, making the transaction a test case for its broader asset-sale strategy.